Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis

Le Shen, Kang Han, Lei Bo, Fei Huang

Open source

DOI
10.1016/j.clinsp.2026.101147
Published
2026-01
Container
Clinics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clinsp.2026.101147,
  title = {Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis},
  author = {Le Shen and Kang Han and Lei Bo and Fei Huang},
  year = {2026},
  journal = {Clinics},
  doi = {10.1016/j.clinsp.2026.101147},
  url = {https://doi.org/10.1016/j.clinsp.2026.101147}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis
AU  - Le Shen
AU  - Kang Han
AU  - Lei Bo
AU  - Fei Huang
PY  - 2026
JO  - Clinics
DO  - 10.1016/j.clinsp.2026.101147
UR  - https://doi.org/10.1016/j.clinsp.2026.101147
ER  - 

APA

Shen, L., Han, K., Bo, L., & Huang, F. (2026). Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis. Clinics. https://doi.org/10.1016/j.clinsp.2026.101147

Source records